JLJoo-Hyun Lee

Joo-Hyun Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joo-Hyun Lee has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anemia as an indicator of a higher retention rate for tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis from a Korean multicenter registry

    by Jung Gon Kim, Bon San Koo, Joo-Hyun Lee, Bo Young Yoon

    Jung Gon Kim, M.D., M.S., Bon San Koo, M.D., Ph.D., Joo-Hyun Lee, M.D., Ph.D., Bo Young Yoon, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2024.0026


  • Open Access

    Novel association between asthma and osteoarthritis: a nationwide health and nutrition examination survey

    by Hyeon-Kyoung Koo, Pamela Song, Joo-Hyun Lee

    Background: Asthma and osteoarthritis (OA) are medical conditions that inhibit physical activity and adversely affect quality of life. Despite the high prevalence, there are limited studies focusing on the comorbid condition and association between asthma and OA. The aim of this study was to assess the prevalence of OA co-occurring with asthma and to identify the relevant clinical considerations. Methods: Adult participants aged over 40 years who completed questionnaire assessments and spirometry tests were enrolled from the Korean National Health and Nutrition Examination Survey. Asthma and OA were defined based on the medical history of a diagnosis made by a doctor. Radiographic severities of OA were measured using the Kellgren–Lawrence grading system. Chronic obstructive pulmonary disease (COPD), as a comparative respiratory disease, was diagnosed based on the spirometric results. Results: A total of 9344 subjects were enrolled, and the prevalence of asthma and COPD were 4.6% ± 0.3% and 12.0% ± 0.5%, respectively. The prevalence of OA in the asthma group was 31.9% ± 2.8%, which was significantly higher than that in the COPD (17.8% ± 1.5%) or control (16.2% ± 0.6%) groups. OA was more prevalent in patients with asthma after adjusting for age, sex, body mass index, and smoking status (OR 1.65; 95% CI 1.27–2.13). Furthermore, after adjustment of this model for the prescription of OA medication, OA remained independently associated with asthma (OR 1.56; 95% CI 1.10–2.20). Conversely, the relationship of OA medication with asthma was not significant (P = 0.64). This relationship was evident in patients with asthma without airflow limitation measured by spirometry (OR 1.97; 95% CI 1.32–2.93). Moreover, the radiographic severity of knee OA correlated with asthma (OR 1.10; 95% CI 1.0–‍‍1.21). Conclusions: OA shows a high prevalence in patients with asthma, higher than in patients with COPD or the controls. The comorbid characteristics of these two conditions need to be considered in clinical practice.


  • Open Access

    Novel Association Between Asthma and Osteoarthritis: A Nationwide Health and Nutrition Examination Survey

    by Hyeon-Kyoung Koo, Pamela Song, Joo-Hyun Lee

    Backgrounds: Asthma and osteoarthritis (OA) are medical conditions that disable physical activity and deteriorate patients’ quality of life. Despite the high prevalence, there are limited studies focusing on the comorbid condition and association between asthma and OA. The aim of study was to assess the prevalence and identify the clinical considerations for this special population.Methods: Adult patients aged over 40 years who completed questionnaire assessments and spirometry were enrolled from Korean National Health and Nutrition Examination Survey. Asthma and OA were defined on the history of doctor-diagnosed disease. Radiographic severities of OA were measured using the Kellgren/Lawrence grading system. Chronic obstructive pulmonary disease (COPD) as a comparative respiratory disease was diagnosed on the basis of spirometric results.Results: A total of 9344 subjects were enrolled, and the prevalence of asthma and COPD were 4.6%±0.3% and 12.0%±0.5%, respectively. The prevalence of OA in the asthma group was 31.9%±2.8%, which was significantly higher than those in the COPD (17.8%±1.5%) or control (16.2%±0.6%) groups. OA was more prevalent in asthma patients after adjusting for age, sex, body mass index, and smoking status (OR, 1.65; 95% CI, 1.27-2.13). After further adjustment of this model for prescription of OA medication, OA was still independently associated with asthma (OR, 1.56; 95% CI, 1.10-2.20). In contrast, the relationship of OA medication with asthma was not significant (P=0.64). This relationship was evident in subjects with asthma without airflow limitation measured by spirometry (OR, 1.97; 95% CI, 1.32-2.93). Moreover, radiographic severity of knee OA correlated with asthma (OR, 1.10; 95% CI, 1.0-1.21). Conclusions: OA shows a high prevalence in patients with asthma, with the prevalence being higher than that in COPD patients or controls. The comorbid characteristics of these two conditions need to be considered in clinical practice.

  • Open Access

    The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease

    by Yu Bin Seo, Su-Jin Moon, Chan Hong Jeon, Joon Young Song, Yoon-Kyoung Sung, Su Jin Jeong, Ki Tae Kwon, Eu Suk Kim, Jae-Hoon Kim, Hyoun-Ah Kim, et al.

    To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.


  • Open Access

    Association of Serum Uric Acid with Cardiovascular Disease Risk Scores in Koreans

    by Seung Yun Lee, Won Park, Young Ju Suh, Mie Jin Lim, Seong-Ryul Kwon, Joo-Hyun Lee, Young Bin Joo, Youn-Kyung Oh, Kyong-Hee Jung

    As the prevalence of gout and hyperuricemia increases, the comorbidities of gout and hyperuricemia have become a public health burden. In particular, risks of cardiovascular disease (CVD)-related complications are increasing. However, a few guidelines exist for the management of hyperuricemia. This cross-sectional study aimed to investigate the association of serum uric acid with CVD risk in the general population of Korean adults. We examined cross-sectional data from the first and second years of the seventh Korea National Health and Nutrition Examination Survey 2016–2017. Among 16,277 participants, 8781 were analyzed. We estimated the CVD risk using a 10-year CVD risk score prediction formula. There was a significant association of serum uric acid with 10-year CVD risk scores after adjusting for physical activity, body mass index, serum creatinine, and alcohol consumption in both sexes (p < 0.001). In the fitted fractional polynomial model, an approximate U-shaped association between serum uric acid levels and 10-year CVD risk scores was found in men. At the serum uric acid level of 6.9 mg/dL, the CVD risk was lowest. An approximate J-shaped association between serum uric acid levels and 10-year CVD risk scores was found in women. Our study showed that hyperuricemia was associated with an increased CVD risk. Hypouricemia was also associated with an increased CVD risk in men. We, therefore, recommend proper management of uric acid levels in the general population to reduce CVD risks.


  • Open Access

    Application of a Novel Diagnostic Rule in the Differential Diagnosis between Acute Gouty Arthritis and Septic Arthritis

    by Kwang-Hoon Lee, Sang-Tae Choi, Soo-Kyung Lee, Joo-Hyun Lee, Bo-Young Yoon

    Lee KH, et al. J Korean Med Sci. 2015 Jun;30(6):700-704. https://doi.org/10.3346/jkms.2015.30.6.700


  • Open Access

    Seasonality of Gout in Korea: A Multicenter Study

    by Hyo Jin Choi, Chan Hee Lee, Joo Hyun Lee, Bo Young Yoon, Hyoun Ah Kim, Chang Hee Suh, Sang Tae Choi, Jung Soo Song, HoYeon Joo, Sung Jae Choi, et al.

    Choi HJ, et al. J Korean Med Sci. 2015 Mar;30(3):240-244. http://dx.doi.org/10.3346/jkms.2015.30.3.240


  • Open Access

    The Influence of Vertebral Fracture on the Functional Disability of Patients with Rheumatoid Arthritis

    by Soo-Kyung Cho, Joo-Hyun Lee, Minkyung Han, Seunghun Lee, Ji Young Kim, Jeong Ah Ryu, Yun Young Choi, Sang-Cheol Bae, Yoon-Kyoung Sung

    Cho SK, et al. J Korean Med Sci. 2014 Jun;29(6):859-863. https://doi.org/10.3346/jkms.2014.29.6.859